Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
32 hedge funds and large institutions have $11.6M invested in Miromatrix Medical Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 0 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
3% more funds holding
Funds holding: 31 → 32 (+1)
5% more capital invested
Capital invested by funds: $11.1M → $11.6M (+$522K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$63.6K |
| 2 |
BlackRock
New York
|
+$24.2K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$17.6K |
| 4 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
+$13.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$11.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIPM
G2 Investment Partners Management
New York
|
-$76.6K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$42.2K |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$11.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.52K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $5.84K | +$2.69K | +2,038 | +157% |
|
|
27
UBS Group
Zurich,
Switzerland
| $3.56K | -$6.52K | -4,943 | -71% |
|
28
Morgan Stanley
New York
| $1.75K | – | – | – |
|
29
Simplex Trading
Chicago,
Illinois
| $1K | +$1.13K | +856 | New |
|
30
Osaic Holdings
Scottsdale,
Arizona
| $350 | – | – | – |
|
31
Wells Fargo
San Francisco,
California
| $289 | +$67 | +51 | +45% |
|
|
HI
32
Harbour Investments
Madison,
Wisconsin
| $67 | – | – | – |
|
MIRO Hedge Fund Activity: Q2 2023 in Review
32 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q2 2023, worth a combined $11.6M — up 4.7% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MIRO positions and 0 closed out — a net gain of 1 holder — while 11 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $63.6K. The largest seller was G2 Investment Partners Management, cutting an estimated $76.6K.
- 32 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q2 2023, up from 31 in Q1 2023.
- Funds reported $11.6M of Miromatrix Medical Inc. Common Stock stock for Q2 2023, up 4.7% quarter-over-quarter.
- 1 fund opened new Miromatrix Medical Inc. Common Stock positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q2 2023 was Geode Capital Management, an estimated $63.6K added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q2 2023 was G2 Investment Partners Management, an estimated $76.6K sold.
Based on aggregated 13F filings for Q2 2023.